Inactivation Gate Peptide
|
INACTIVATION GATE PEPTIDE
|
156162-44-6
|
H-Val-Val-Val-NH2
|
|
|
H-Val-Val-Val-OH
|
H-VAL-VAL-VAL-OH
|
28130-13-4
|
H-β-Ala-Leu-OH
|
H-Β-ALA-LEU-OH
|
17136-25-3
|
H-β-Ala-Trp-OH
|
H-Β-ALA-TRP-OH
|
21612-37-3
|
H-β-Ala-Phe-OH
|
Β-丙氨酰苯丙氨酸
|
17136-28-6
|
Hypertrehalosaemic Neuropeptide (Heliothis zea)
|
PYR-LEU-THR-PHE-SER-SER-GLY-TRP-GLY-ASN-NH2
|
117107-54-7
|
H-Val-β-Ala-OH
|
H-VAL-Β-ALA-OH
|
30806-08-7
|
Hypertrehalosaemic Neuropeptide (Nauphoeta cinerea)
|
HYPERTREHALOSAEMIC NEUROPEPTIDE (NAUPHOETA CINEREA)
|
106018-36-4
|
Pyr-Phe-Trp-Lys-Tyr-OH
|
|
|
Pyr-Phe-OH
|
PYR-PHE-OH
|
21282-12-2
|
Pyr-Leu-Leu-Gly-Gly-Arg-Phe-Gly-Tyr-OH
|
PYR-LEU-LEU-GLY-GLY-ARG-PHE-GLY-TYR-OH
|
|
Pyr-Gly-OH
|
PYR-GLY-OH
|
29227-88-1
|
Pyr-Gly-Gly-Leu-Arg-Trp-NH2
|
PYR-GLY-GLY-LEU-ARG-TRP-NH2
|
328085-50-3
|
Pyr-Phe-Leu-pNA
|
PYR-PHE-LEU-PNA
|
85901-57-1
|
Pyr-Pro-Arg-pNA hydrochloride salt
|
PYR-PRO-ARG-PNA
|
72194-57-1
|
Pyr-Phe-Gly-NH2
|
PYR-PHE-GLY-NH2
|
203396-25-2
|
H-Val-Val-Val-Val-OH
|
H-VAL-VAL-VAL-VAL-OH
|
64577-64-6
|
H-Val-Val-Lys-OH
|
H-Val-Val-Lys-OH
|
73015-99-3
|
H-β-Ala-Gly-Gly-OH
|
|
|
H-β-Ala-Lys-OH · HCl
|
H-Β-ALA-LYS-OH HCL
|
90970-40-4
|
H-β-Ala-Gly-Ala-OH
|
|
|
Influenza PR8 Hemagglutinin Peptide (110-119) trifluoroacetate salt
|
SER-PHE-GLU-ARG-PHE-GLU-ILE-PHE-PRO-LYS
|
132031-50-6
|
Hymenistatin I
|
HYMENISTATIN I
|
129536-23-8
|
Intermedin-53 (human)
|
HIS-SER-GLY-PRO-ARG-ARG-THR-GLN-ALA-GLN-LEU-LEU-ARG-VAL-GLY-CYS-VAL-LEU-GLY-THR-CYS-GLN-VAL-GLN-ASN-LEU-SER-HIS-ARG-LEU-TRP-GLN-LEU-MET-GLY-PRO-ALA-GLY-ARG-GLN-ASP-SER-ALA-PRO-VAL-ASP-PRO-SER-SER-PRO-HIS-SER-TYR-NH2
|
1140977-96-3
|
Insulin Receptor (689-702)
|
INSULIN RECEPTOR (689-702)
|
|
H-Val-Val-Phe-OH
|
H-VAL-VAL-PHE-OH
|
153247-47-3
|
H-Val-Val-OH
|
H-VAL-VAL-OH
|
3918-94-3
|
H-β-Ala-Val-OH
|
H-Β-ALA-VAL-OH
|
17136-26-4
|
H-β-Ala-β-Ala-β-Ala-OH
|
3-[3-(3-氨基丙酰氨基)丙酰氨基]丙酸
|
69010-59-9
|
H-Val-Val-Gln-OH
|
H-VAL-VAL-GLN-OH
|
212207-62-0
|
H-Val-Tyr-Ser-βNA hydrochloride salt
|
H-VAL-TYR-SER-ΒNA
|
13989-68-9
|
H-Val-Tyr-Val-OH
|
H-VAL-TYR-VAL-OH
|
17355-22-5
|
Lysozyme C (46-61) (chicken) trifluoroacetate salt
|
雞蛋白溶菌酶多肽46-61
|
62982-31-4
|
Matrix Protein M1 (58-66) (Influenza A virus) acetate salt
|
GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU
|
141368-69-6
|
N-[(RS)-1-Carboxy-3-phenyl-propyl]-Ala-Ala-Phe-4-Abz-OH trifluoroacetate salt
|
4-[[(1S)-1-[[(2S)-2-[[(2S)-2-[(1-carboxy-3-phenyl-propyl)amino]propano yl]amino]propanoyl]carbamoyl]-2-phenyl-ethyl]amino]benzoic acid
|
116560-97-5
|
Lys-Thymic Factor trifluoroacetate salt
|
H-LYS-GLU-ALA-LYS-SER-GLN-GLY-GLY-SER-ASN-OH TRIFLUOROACETATE SALT
|
318950-01-5
|
M65 trifluoroacetate salt
|
M65
|
1872440-65-7
|
NFAT Inhibitor trifluoroacetate salt
|
NFAT INHIBITOR
|
249537-73-3
|
Nocistatin (bovine) trifluoroacetate salt
|
NOCISTATIN (BOVINE)
|
208253-85-4
|
Macrophage Inhibitory Peptide
|
THR-LYS-PRO
|
41961-56-2
|
Neuropeptide GE
|
NEUROPEPTIDE GE
|
134748-04-2
|
L-Ornithine-L-aspartate salt
|
L-鳥氨酸-L-天門冬氨酸鹽
|
3230-94-2
|
Leukotriene A4 (LTA4) Hydrolase (365-385) (human)
|
LEUKOTRIENE A4 (LTA4) HYDROLASE (365-385) (HUMAN)
|
|
Litorin
|
GLP-GLN-TRP-ALA-VAL-GLY-HIS-PHE-MET-NH2
|
55749-97-8
|
Locustakinin I
|
LOCUSTAKININ I
|
139602-08-7
|
LIP2 (human)
|
LIP2 (HUMAN)
|
1872440-46-4
|
Lymphocyte Activating Pentapeptide
|
LEU-PRO-PRO-SER-ARG
|
120484-65-3
|
Locustamyotropin IV
|
LOCUSTAMYOTROPIN IV
|
143907-81-7
|
LIP1 (human) trifluoroacetate salt
|
LIP1 (human)
|
1872435-03-4
|
LymnaDFamide-1
|
LYMNADFAMIDE-1
|
148596-98-9
|
Levitide
|
LEVITIDE
|
114281-19-5
|
Leech Osmoregulatory Factor
|
LEECH OSMOREGULATORY FACTOR
|
175413-77-1
|
Lactoferrin N-Lobe (231-245) (human)
|
LACTOFERRIN N-LOBE (231-245) (HUMAN)
|
169056-32-0
|
Kemptamide trifluoroacetate salt
|
LYS-LYS-ARG-PRO-GLN-ARG-ALA-THR-SER-ASN-VAL-PHE-SER-NH2
|
89315-28-6
|
Kentsin
|
KENTSIN?H-THR-PRO-ARG-LYS-OH
|
56767-30-7
|
KALA Amphipathic Peptide
|
KALA AMPHIPATHIC PEPTIDE
|
|
Isovaleryl-Phe-Lys-pNA · HCl
|
ISOVALERYL-PHE-LYS-PNA · HCL
|
178894-43-4
|
Peptide M
|
鏈球菌M蛋白多肽
|
110652-62-5
|
Peptide 6A
|
PEPTIDE 6A
|
73549-32-3
|
Osteopontin (131-137) (mouse)
|
OSTEOPONTIN (131-137) (MOUSE)
|
577725-62-3
|
Peptide WE-14
|
TRP-SER-LYS-MET-ASP-GLN-LEU-ALA-LYS-GLU-LEU-THR-ALA-GLU
|
115136-18-0
|
Peptide 74
|
PEPTIDE 74
|
132116-39-3
|
Peptide 810
|
PEPTIDE 810
|
156371-22-1
|
Peptitergent PD1
|
|
|
Orcokinin
|
ORCOKININ
|
145344-97-4
|
Peptide 46
|
PEPTIDE 46
|
192122-40-0
|
Pedibin Precursor (hydra)
|
PEDIBIN PRECURSOR (HYDRA)
|
|
Opiorphin trifluoroacetate salt
|
OPIORPHIN
|
864084-88-8
|
Ophthalmic Acid
|
OPHTHALMIC ACID
|
495-27-2
|
Pepzyme
|
|
|
Protein G B1 Domain (41-56)
|
PROTEIN G B1 DOMAIN (41-56)
|
160291-75-8
|
Preangiotensinogen (11-14) (human) acetate salt
|
ANGIOTENSINOGEN FRAGMENT 11-14
|
102813-98-9
|
Phospholipase A2 Activating Peptide
|
PHOSPHOLIPASE A2 ACTIVATING PEPTIDE
|
137314-60-4
|
Protein Fragment (187-204)
|
PROTEIN Τ FRAGMENT (187-204)
|
|
Prepro-Nerve Growth Factor (99-115) (mouse)
|
PRO-GLU-ALA-HIS-TRP-THR-LYS-LEU-GLN-HIS-SER-LEU-ASP-THR-ALA-LEU-ARG
|
|
Pheromone Biosynthesis Activating Neuropeptide (Helicoverpa assulta, Heliothis zea)
|
HEZ-PBAN
|
122071-54-9
|
Pyr-Gln-OH
|
PYR-GLN-OH
|
109481-23-4
|
Pol-RFamide
|
POL-RFAMIDE
|
119116-89-1
|
Pyr-Arg-Thr-Lys-Arg-AMC trifluoroacetate salt
|
PYR-ARG-THR-LYS-ARG-AMC
|
155575-02-3
|
Pyr-Ala-OH
|
焦谷氨酰丙氨酸(無100MG包裝)
|
21282-08-6
|
Phenylac-Gly-Lys-OH
|
N-PHENYLACETYL-GLY-LYS
|
113969-25-8
|
p-Hydroxy-Bz-Ala-Phe-OH
|
|
92279-13-5
|
Phylloseptin-L2
|
|
1100546-22-2
|
Proctolin
|
ARG--TYR--LEU--PRO-THR
|
57966-42-4
|
Pheromonotropin (Pseudaletia separata)
|
|
|
Phospholipase A2 Fragment (70-74)
|
|
147139-72-8
|
Perisulfakinin
|
perisulfakinin
|
125131-58-0
|
H-Val-Trp-Ile-OH
|
H-VAL-TRP-ILE-OH
|
|
H-Val-Leu-Ser-OH
|
H-VAL-LEU-SER-OH
|
|
H-Val-Lys-OH
|
纈氨酰賴氨酸
|
22677-62-9
|
H-Val-Pro-OtBu
|
H-VAL-PRO-OTBU · HCL
|
60108-51-2
|
H-Val-Met-OH
|
L-纈氨酰-L-蛋氨酸
|
14486-09-0
|
H-Val-Tyr-NH2
|
H-VAL-TYR-NH2 · HCL
|
126712-17-2
|
H-Val-Lys-Lys-Arg-OH
|
H-VAL-LYS-LYS-ARG-OH
|
286471-39-4
|
H-Val-Ser-OH
|
H-VAL-SER-OH
|
13588-94-8
|
H-Val-Pro-OH
|
H-VAL-PRO-OH · HCL
|
105931-64-4
|
H-Val-Tyr-Pro-OH
|
H-VAL-TYR-PRO-OH
|
68076-97-1
|
H-Val-Phe-OH
|
H-VAL-PHE-OH
|
3918-92-1
|
H-Val-Phe-NH2
|
H-VAL-PHE-NH2 · HCL
|
129678-27-9
|